Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | BWAY |
---|---|---|
09:32 ET | 1116 | 9.75 |
09:35 ET | 500 | 9.77 |
09:46 ET | 383 | 9.75 |
09:48 ET | 100 | 9.82 |
09:53 ET | 155 | 9.7298 |
09:55 ET | 100 | 9.6736 |
10:00 ET | 100 | 9.82 |
10:13 ET | 400 | 9.8097 |
10:31 ET | 700 | 9.6614 |
10:33 ET | 300 | 9.7 |
10:38 ET | 400 | 9.75 |
10:40 ET | 200 | 9.75 |
10:58 ET | 200 | 9.8 |
11:09 ET | 100 | 9.815 |
11:18 ET | 372 | 9.815 |
11:20 ET | 200 | 9.84 |
11:38 ET | 200 | 9.87 |
11:45 ET | 100 | 9.75 |
11:48 ET | 100 | 9.805 |
12:01 ET | 100 | 9.84 |
12:03 ET | 1700 | 9.84 |
12:08 ET | 200 | 9.85 |
12:14 ET | 200 | 9.7814 |
12:15 ET | 100 | 9.92 |
12:21 ET | 100 | 9.91 |
12:24 ET | 100 | 9.98 |
12:28 ET | 200 | 9.99 |
12:30 ET | 1100 | 9.93 |
12:32 ET | 400 | 9.92 |
12:35 ET | 407 | 9.93 |
12:39 ET | 100 | 9.8801 |
12:44 ET | 200 | 9.88 |
12:48 ET | 100 | 9.94 |
12:50 ET | 200 | 9.91 |
12:53 ET | 167 | 9.9399 |
12:57 ET | 100 | 9.93 |
01:00 ET | 603 | 9.905 |
01:04 ET | 700 | 9.93 |
01:08 ET | 979 | 9.87 |
01:09 ET | 100 | 9.9 |
01:18 ET | 900 | 9.895 |
01:31 ET | 100 | 9.87 |
01:33 ET | 100 | 9.89 |
01:47 ET | 1113 | 9.84 |
01:54 ET | 897 | 9.88 |
02:02 ET | 800 | 9.82 |
02:09 ET | 500 | 9.751 |
02:50 ET | 1500 | 9.85 |
02:54 ET | 2687 | 9.91 |
03:01 ET | 180 | 9.8661 |
03:03 ET | 200 | 9.86 |
03:06 ET | 100 | 9.87 |
03:15 ET | 100 | 9.92 |
03:35 ET | 100 | 9.86 |
03:42 ET | 200 | 9.85 |
03:53 ET | 127 | 9.8323 |
04:00 ET | 1804 | 9.84 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Brainsway Ltd | 182.4M | -19.4x | --- |
Neuropace Inc | 268.6M | -9.1x | --- |
Edap Tms SA | 92.4M | -4.0x | --- |
Electromed Inc | 235.9M | 38.7x | +20.42% |
908 Devices Inc. | 95.0M | -1.5x | --- |
Owlet Inc | 69.5M | -2.7x | --- |
Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $182.4M |
---|---|
Revenue (TTM) | $63.6M |
Shares Outstanding | 18.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.24 |
EPS | $-0.51 |
Book Value | --- |
P/E Ratio | -19.4x |
Price/Sales (TTM) | 2.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -15.60% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.